Literature DB >> 17317473

Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.

D Riccio1, A Solinas, G Astara, G Mantovani.   

Abstract

The most visible manifestation of dementia is the progressive inability to activities of daily living (ADL) and to instrumental activities of daily living (IADL). The comprehensive geriatric assessment (CGA) is the validated and recommended instrument to a correct evaluation and decision making in elderly patients. To judge if the decline in cognitive functions is associated with a worsening in functional, emotional and clinical status measured by CGA, we also compared CGA in the same patients stratified for mild, moderate and severe dementia. From September 2004 to November 2005 we studied 47 institutionalized female patients with Alzheimer's disease (AD) and other types of dementia. Mean age was 83.70+/-0.88 years (range 70-101). Their multidimensional evaluation was performed by the CGA. We evaluated geriatric syndromes (AGS, 2004), polypharmacy, frailty, hemoglobin (Hb), serum creatinine (CR) and white blood cells (WBC). We stratified the population in 3 groups for the mini mental state examination (MMSE): severe (MMSE 0-9; 5 patients), moderate (MMSE 10-29; 23 patients) and mild dementia group (MMSE 20-30; 19 patients), and searched for statistical differences in the parameters of CGA. MMSE was significantly related to dependence in ADL (mean=x=1.85), IADL (x=0.57), cumulative illness rating scale-geriatrics (CIRS-G) (x=9.55), geriatric depression scale (GDS) (x=8.71), geriatric syndromes (x=2.49), Hb, CR, WBC and number of drugs (x=6.51, range 2-15) (p=0.001). MMSE low score was also correlated with a worse mini nutritional assessment (MNA) (x=19.5; p=0.003). Frail patients were 61.7%. We found a statistically significant difference in the prevalence of geriatric syndromes between mild vs. moderate dementia group (p=0.02). Mild vs. moderate group, and moderate vs severe group were significantly different concerning Hb levels (p=0.009 and 0.002, respectively). Patients with severe cognitive impairment are more likely to be dependent at ADL and IADL; to present a larger number of comorbidity and geriatric syndromes; to have lower !evels of Hb and higher levels of CR; to be in a worse nutritional status and to take a larger number of drugs. Polypharmacy maybe related to high comorbidity but the risk of irrational drug use should be evaluated. We suggest single testing with CGA as an effective tool providing a comprehensive assessment of elderly, and able to detect unaddressed corrigible problems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317473     DOI: 10.1016/j.archger.2007.01.047

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  5 in total

1.  Older rehabilitation patients are at high risk of malnutrition: evidence from a large Australian database.

Authors:  K E Charlton; C Nichols; S Bowden; K Lambert; L Barone; M Mason; M Milosavljevic
Journal:  J Nutr Health Aging       Date:  2010-10       Impact factor: 4.075

2.  Determinants of living situation in a population of community-dwelling and assisted living-dwelling elders.

Authors:  Erika Avery; Alison Kleppinger; Richard Feinn; Anne M Kenny
Journal:  J Am Med Dir Assoc       Date:  2010-01-06       Impact factor: 4.669

3.  Nutritional predictors of cognitive impairment severity in demented elderly patients: the key role of BMI.

Authors:  A Coin; N Veronese; M De Rui; M Mosele; F Bolzetta; A Girardi; E Manzato; G Sergi
Journal:  J Nutr Health Aging       Date:  2012       Impact factor: 4.075

4.  [Medication in the elderly : cognitive impairment by drugs].

Authors:  M Wehling
Journal:  Internist (Berl)       Date:  2012-10       Impact factor: 0.743

5.  Decreased activity of daily living produced by the combination of Alzheimer's disease and lower limb fracture in elderly requiring nursing care.

Authors:  Toshimitsu Inagawa; Toshio Hamagishi; Yuji Takaso; Yoshiaki Hitomi; Yasuhiro Kambayashi; Yuri Hibino; Aki Shibata; Nguyen T M Ngoc; Jiro Okochi; Kotaro Hatta; Kiyoshi Takamuku; Tadashi Konoshita; Hiroyuki Nakamura
Journal:  Environ Health Prev Med       Date:  2012-05-11       Impact factor: 3.674

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.